Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer.

@article{LuYao2014FifteenyearSO,
  title={Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer.},
  author={Grace L. Lu-Yao and Peter C Albertsen and Dirk F Moore and Weichung Joe Shih and Yong Qi Lin and Robert S. DiPaola and S Yao},
  journal={JAMA internal medicine},
  year={2014},
  volume={174 9},
  pages={1460-7}
}
IMPORTANCE One in 6 American men will be diagnosed as having prostate cancer during their lifetime. Although there are no data to support the use of primary androgen-deprivation therapy (ADT) for early-stage prostate cancer, primary ADT has been widely used for localized prostate cancer, especially among older patients. OBJECTIVE To determine the long-term survival impact of primary ADT in older men with localized (T1/T2) prostate cancer. DESIGN, SETTING, AND PARTICIPANTS This was a… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 60 times over the past 90 days. VIEW TWEETS
24 Citations
27 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 24 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 27 references

Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer

  • GL Lu-Yao, PC Albertsen, DF Moore
  • [published online July
  • 2014

Similar Papers

Loading similar papers…